Technological Advancements And Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth

DUBLIN, Oct. 26, 2023 /PRNewswire/ -- The "Global Neuromuscular Disease Therapeutics Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.

The global neuromuscular disease therapeutics market is set to witness substantial growth, with a projected increase of USD 6.51 billion during the period 2022-2027, at a robust CAGR of 10.3%.

This forecast is outlined in the comprehensive report on the neuromuscular disease therapeutics market, which offers a holistic analysis encompassing market size, trends, growth drivers, challenges, and an in-depth vendor analysis, featuring approximately 25 key industry players.

The report presents an up-to-date analysis of the current market scenario, highlighting the latest trends, influential drivers, and the overall market environment. Key factors propelling market growth include the emergence of novel approvals for neuromuscular disease therapeutics, a surge in newborn screening tests, and a substantial unmet need for effective treatments in this sector.

Segmentation of the neuromuscular disease therapeutics market includes:

By Type

Biologics
Small molecules

By End-user

Hospitals
Clinics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

One of the pivotal drivers fueling the growth of the neuromuscular disease therapeutics market is the technological advancements in neuromuscular disease therapy. Additionally, the hereditary nature of neuromuscular diseases and the escalating research efforts dedicated to developing therapeutics for these conditions are expected to drive substantial demand in the market over the coming years.

The report on the neuromuscular disease therapeutics market encompasses the following key areas:

Neuromuscular Disease Therapeutics Market Sizing
Neuromuscular Disease Therapeutics Market Forecast
Neuromuscular Disease Therapeutics Market Industry Analysis

The report provides a comprehensive vendor analysis, featuring prominent industry players, including:

Aquestive Therapeutics Inc.
Bausch Health Companies Inc.
Biogen Inc.
Brainstorm Cell Therapeutics Inc.
Cytokinetics Inc.
F. Hoffmann La Roche Ltd.
Ionis Pharmaceuticals Inc.
Mitsubishi Chemical Corp.
Mylan NV
Nippon Shinyaku Co. Ltd.
Novartis AG
Pfizer Inc.
PTC Therapeutics Inc.
Sanofi
Sarepta Therapeutics Inc.
SGPharma Pvt. Ltd.
Sun Pharmaceutical Industries Ltd.
Troikaa Pharmaceuticals Ltd.
Viatris Inc.
AFM-Telethon

With an expanding neuromuscular disease therapeutics market, the prospects for growth and innovation in this sector are promising. Market participants are encouraged to leverage these insights and opportunities to make informed decisions and contribute to the advancement of neuromuscular disease treatment.

For more information about this report visit https://www.researchandmarkets.com/r/2z6zf1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/technological-advancements-and-research-efforts-propel-neuromuscular-disease-therapeutics-market-growth-301969180.html

SOURCE Research and Markets

First published on Fri, Oct 27, 2023

Enjoyed what you read? Great news – there’s a lot more to explore!

Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!

Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.

Head to the TechDogs homepage to Know Your World of technology today!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Tags:

ResearchAndMarkets Neuromuscular Disease Therapeutics Biologics Aquestive Therapeutics Ionis Pharmaceuticals

Join The Discussion

Corgi Launches AI Insurance Coverage To Protect Businesses When AI Goes Wrong

IBM And Aramco Explore Collaboration To Accelerate AI And Innovation Across Saudi Arabia

IGT Solutions Rebrands As Atain, Marking A New Era As An Enterprise Orchestration Partner

Elevate Appoints Wade Clark As Chief Growth Officer

Tangible Growth And SAP Signavio Announce Strategic Partnership To Bring Corporate Strategy To Business Transformation